Search results - 16 results
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
age-specific prevalences for any HPV, high-risk (HR)- HPV, and individual HPV types were estimated using random-effects models for meta-analysis and grouped by UN Sustainable Development Goals ...
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening
testing compared to conventional invitations and to compare different self-sampling invitation scenarios. Four experimental invitational scenarios were considered. Women in the control group were invited ...
The European response to the WHO call cervical cancer as a public health problem
achieve 70% of screening coverage in the target age group, providing also HPV testing on self‐samples for non‐ or under‐screened women; and to manage 90% of screen‐positive women. To guide member states, ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
least 90% of girls by age 15 years, by offering screening at least twice in a lifetime to 70% or more of the target age populations and treat more than 90% of women with screen-detected lesions. Recently, ...
Des patients cancéreux parlent du ngs: Étude de groupe de discussion sur les expériences et les besoins en information
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Wannes Van Hoof; Katrien Moens Source: Sciensano, Brussels, Belgium, p.29 (2019) Keywords: NGS Patient Participation personalised medicine Health Topics: Quality of ...
The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer
the working age population (16–64 years). There is a strong need to assess and understand their reintegration on the labour market, which underlines and ensures their social integration and quality of ...
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
those associated with vaccine HPV types and any cervical precancer. Exposure groups were: women aged: 15-26 or 24-45 years being initially negative for high-risk HPV (hrHPV) or negative for the vaccine ...
Early effects of human papillomavirus vaccination in Belgium.
(RR =0.65, 95% confidence interval=0.29-1.48) was found in the youngest group (15-19 years). The prevalences in the older age group did not change significantly. These findings show the early effects of ...
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
hepatitis B vaccination programme (approximately 80%) offered to boys and girls in the same age group and under the same circumstances. Health Topics: Cancer Cancer Kanker Quality of healthcare Qualité des ...
Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models.
CONCLUSION: Mortality increased with ageing and declined over time in most age-groups, but varied irregularly by birth cohort. In global, with some discrete exceptions, mortality decreased for successive ...